12.38p+0.00 (+0.03%)19 May 2022, 12:12
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.

Scancell Holdings PLC Market & Company News

12.04.2022 15:47SCLPChange of Registered Holder of SharesRNS
11.04.2022 14:06SCLPSecond Price Monitoring ExtnRNS
11.04.2022 14:00SCLPPrice Monitoring ExtensionRNS
11.04.2022 12:15SCLP, ASCL, SBRYLONDON MARKET MIDDAY: France's CAC 40 outperforms on Macron hopeAlliance
11.04.2022 11:17SCLPScancell shares soar as clinical trial opens for recruitmentAlliance
11.04.2022 11:05SCLPSecond Price Monitoring ExtnRNS
11.04.2022 11:00SCLPPrice Monitoring ExtensionRNS
11.04.2022 07:00SCLPModi-1 Phase 1/2 trial open for recruitmentRNS
29.03.2022 20:21SCLPIN BRIEF: Scancell broadens Covidity clinical trial in South AfricaAlliance
29.03.2022 07:00SCLPUpdate on COVIDITY clinical trialRNS
17.03.2022 21:02MOS, HUR, BKYTRADING UPDATES: SimiGon merger to go ahead; Segro launches green bondAlliance
17.03.2022 07:00SCLPScancell progresses its new anti-glycan mAbRNS
03.03.2022 09:55SCLPDirector DealingRNS
22.02.2022 11:50SCLPImage Scan sinks as it expects to post significant loss in first halfAlliance
31.01.2022 07:00SCLPUpdate on COVIDITY Phase 1 clinical trialRNS
26.01.2022 07:00SCLPInterim Results for the 6 months ended 31 Oct 2021RNS
22.12.2021 09:45SCLPNotice of Interim ResultsRNS
13.12.2021 16:41SCLPSecond Price Monitoring ExtnRNS
13.12.2021 16:36SCLPPrice Monitoring ExtensionRNS
23.11.2021 15:58SCLPResult of AGMRNS
19.11.2021 07:00SCLPFirst patient dosed in SCIB1 Phase 2 trialRNS
03.11.2021 10:28SCLPDirector DealingRNS
02.11.2021 10:07SCLPDirector DealingRNS
01.11.2021 09:50SCLPNotice of Annual General MeetingRNS
29.10.2021 07:00SCLPResults for the year ended 30 April 2021RNS
28.10.2021 11:23SCLPExtension of CLN Redemption DatesRNS
19.10.2021 07:00SCLPNew facilities at The Oxford Science ParkReach
15.10.2021 07:00SCLPNotice of Final ResultsRNS
05.10.2021 16:22SCLPFirst subject dosed in COVIDITY clinical trialRNS
09.09.2021 16:31SCLPPDMR dealingRNS
26.08.2021 07:00SCLPModi-1 Phase I/II CTA approved by MHRARNS
17.08.2021 07:00SCLPScancell selects PharmaJet’s Needle-free SystemsRNS
30.07.2021 09:52SCLPDirector DealingRNS
29.07.2021 07:00SCLPCOVIDITY Phase 1 trial application in SA approvedRNS
28.07.2021 17:00SCLPLindy Durrant appointed CEO of ScancellRNS
22.06.2021 07:00SCLPCOVIDITY trial planned in South Africa and UKRNS
15.06.2021 07:00SCLPAppointment of Joint BrokerRNS
08.06.2021 16:41SCLPSecond Price Monitoring ExtnRNS
08.06.2021 16:35SCLPPrice Monitoring ExtensionRNS
07.06.2021 08:49SCLPDirector DealingRNS
30.04.2021 10:48SCLPDirector DealingRNS
10.03.2021 09:58SCLPHolding(s) in CompanyRNS
02.03.2021 16:40SCLPSecond Price Monitoring ExtnRNS
02.03.2021 16:35SCLPPrice Monitoring ExtensionRNS
19.02.2021 15:00SCLPDirector DealingRNS
19.02.2021 07:00SCLPDirector DealingRNS
17.02.2021 14:04SCLPDirector DealingRNS
16.02.2021 15:00SCLPBLOCK LISTING SIX MONTHLY RETURNRNS
15.02.2021 15:36SCLPStatement regarding share price movementRNS
15.02.2021 11:05SCLPSecond Price Monitoring ExtnRNS
15.02.2021 11:00SCLPPrice Monitoring ExtensionRNS
15.02.2021 09:05SCLPSecond Price Monitoring ExtnRNS
15.02.2021 09:00SCLPPrice Monitoring ExtensionRNS
03.02.2021 07:00SCLPUpdate on SCIB2 clinical development partnershipRNS
29.01.2021 07:00SCLPInterim Results for the 6 months ended 31 Oct 2020RNS
Showing 1 to 55 of 55